|
|
|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
|
Z-3100-2024 - Atellica IM CA 19-9 (50 Test)-In vitro diagnostic use in the quantitative measurement of the CA 19-9 tumor-associated antigen in human serum using the Atellica CI and Atellica IM Analyzers
SMN: 10995...
|
2
|
09/11/2024
|
FEI # 1219913 Siemens Healthcare Diagnostics, Inc.
|
|
Z-3101-2024 - Atellica IM CA 19-9 (250 Test)- In vitro diagnostic use in the quantitative measurement of the CA 19-9 tumor-associated antigen in human serum using the Atellica CI and Atellica IM Analyzers
SMN:1...
|
2
|
09/11/2024
|
FEI # 1219913 Siemens Healthcare Diagnostics, Inc.
|
|
Z-3104-2024 - ADVIA Centaur CA 19-9 (250 Test)-In vitro diagnostic use in the quantitative measurement of the CA 19-9 tumor-associated antigen in human serum using the Atellica CI and Atellica IM Analyzers
SMN: ...
|
2
|
09/11/2024
|
FEI # 1219913 Siemens Healthcare Diagnostics, Inc.
|
|
Z-3103-2024 - ADVIA Centaur CA 19-9 (50 Test)-In vitro diagnostic use in the quantitative measurement of the CA 19-9 tumor-associated antigen in human serum using the Atellica CI and Atellica IM Analyzers
SMN: 104...
|
2
|
09/11/2024
|
FEI # 1219913 Siemens Healthcare Diagnostics, Inc.
|
|
Z-3102-2024 - Atellica IM CA 19-9 (250 Test - REF)-In vitro diagnostic use in the quantitative measurement of the CA 19-9 tumor-associated antigen in human serum using the Atellica CI and Atellica IM Analyzers
...
|
2
|
09/11/2024
|
FEI # 1219913 Siemens Healthcare Diagnostics, Inc.
|